论文部分内容阅读
ePub3这一被视为出版变革的重要技术的发布,对生物医学期刊出版产生着重要影响。ePub3这一新兴的数字化出版标准,已经得到了国际上多家大型出版机构及互联网公司的支持,在生物医学领域,美国国立医学图书馆(NLM)下属PubMed Central(PMC)、BioMed Central(BMC)等也纷纷加入尝试。本文对ePub3可能对生物医学期刊的数字化出版产生的影响作一展望,并呼吁我国的生物医学期刊应尽快完成基于结构化排版的生产流程再造,以适应这一数字化出版发展潮流。
The release of ePub3, an important technology seen as a publishing revolution, has a major impact on the publication of biomedical journals. ePub3, an emerging digital publishing standard, has received the support of several major international publishers and Internet companies. In the field of biomedicine, PubMed Central (PMC), BioMed Central (BMC), a subsidiary of the National Library of Medicine (NLM) Have also joined the trial. This article looks forward to the prospect that ePub3 may have impact on the digital publication of biomedical journals and calls for biomedical journals in our country to complete the production process reengineering based on structured layout as soon as possible so as to adapt to the trend of digital publishing development.